Alcon and Lensar Call Off Merger episode artwork

EPISODE · Mar 18, 2026 · 6 MIN

Alcon and Lensar Call Off Merger

from Eyewire News: The Podcast · host Eyewire News

Alcon and Lensar provide a major update to their proposed merger; the latest IOL on Johnson & Johnson’s Tecnis platform receives FDA approval; and the FDA issues another CRL to Aldeyra Therapeutics for its investigational dry eye drug reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

Alcon and Lensar Call Off Merger

0:00 6:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 6 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on March 18, 2026.

What is this episode about?

Alcon and Lensar provide a major update to their proposed merger; the latest IOL on Johnson & Johnson’s Tecnis platform receives FDA approval; and the FDA issues another CRL to Aldeyra Therapeutics for its investigational dry eye drug...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!